Retinoic acid and nerve growth factor induce differential regulation of nicotinic acetylcholine receptor subunit expression in SN56 cells

Journal of Neuroscience Research

Volumn 85, Issue 3, 2007, Pages 504-514

  Nilbratt, Mats ^a   Friberg, Linda ^a   Mousavi, Malahat ^a   Marutle, Amelia ^a,b   Nordberg, Agneta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF CENTRAL FLORIDA   (United States)

Author keywords

Acetylcholine receptor; Choline acetyltransferase; Nerve growth factor; Retinoic acid

Indexed keywords

ALPHA3 NICOTINIC ACETYLCHOLINE RECEPTOR; ALPHA4 NICOTINIC ACETYLCHOLINE RECEPTOR; ALPHA5 NICOTINIC ACETYLCHOLINE RECEPTOR; BETA2 NICOTINIC ACETYLCHOLINE RECEPTOR; BETA4 NICOTINIC ACETYLCHOLINE RECEPTOR; BUNGAROTOXIN RECEPTOR; CHOLINE ACETYLTRANSFERASE; EPIBATIDINE; MESSENGER RNA; NERVE GROWTH FACTOR; NICOTINIC RECEPTOR; PROTEIN SUBUNIT; RETINOIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL LINE; CONTROLLED STUDY; MOUSE; NERVE CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL LINE; CHOLINE O-ACETYLTRANSFERASE; DNA PRIMERS; GENE EXPRESSION REGULATION; KINETICS; MICE; NERVE GROWTH FACTOR; PROTEIN SUBUNITS; PYRIDINES; RECEPTORS, CHOLINERGIC; RECEPTORS, NICOTINIC; TRETINOIN;

EID: 33847263471     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21156     Document Type: Article

References (68)

1. Alkondon M, Albuquerque EX. 1993. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J Pharmacol Exp Ther 265:1455-1473.
2. Arroyo-Jim nez MM, Bourgeois JP, Marubio LM, Le Sourd AM, Ottersen OP, Rinvik E, Fairen A, Changeux JP. 1999. Ultrastructural localization of the alpha4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra. J Neurosci 19:6475-6487.
3. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. 1995. Embryonic stem cells express neuronal properties in vitro. Dev Biol 168:342-357.
4. Barbosa J Jr, Ferreira LT, Martins-Silva C, Santos MS, Torres GE, Caron MG, Gomez MV, Ferguson SS, Prado MA, Prado VF. 2002. Trafficking of the vesicular acetylcholine transporter in SN56 cells: a dynamin-sensitive step and interaction with the AP-2 adaptor complex. J Neurochem 82:1221-1228.
5. Berse B, Blusztajn JK. 1995. Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor alpha, cAMP, and leukemia inhibitory factor/ciliary neurotrophic factor signaling pathways in a murine septal cell line. J Biol Chem 270:22101-22104.
6. Berse B, Blusztajn JK. 1997. Modulation of cholinergic locus expression by glucocorticoids and retinoic acid is cell-type specific. FEBS Lett 410:175-179.
7. Berse B, Lopez-Coviella I, Blusztajn JK. 1999. Activation of TrkA by nerve growth factor upregulates expression of the cholinergic gene locus but attenuates the response to ciliary neurotrophic growth factor. Biochem J 342:301-308.
8. Blusztajn JK, Venturini A, Jackson DA, Lee HJ, Wainer BH. 1992. Acetylcholine synthesis and release is enhanced by dibutyryl cyclic AMP in a neuronal cell line derived from mouse septum. J Neurosci 12:793-799.
9. Carpenter MK, Cui X, Hu ZY, Jackson J, Sherman S, Seiger A, Wahlberg LU. 1999. In vitro expansion of a multipotent population of human neural progenitor cells. Exp Neurol 158:265-278.
10. Cavicchioli L, Flanigan TP, Dickson JG, Vantini G, Dal Toso R, Fusco M, Walsh FS, Leon A. 1991. Choline acetyltransferase messenger RNA expression in developing and adult rat brain: regulation by nerve growth factor. Brain Res Mol Brain Res 9:319-325.
11. Cervini R, Berrard S, Bejanin S, Mallet J. 1994. Regulation by CDF/LIF and retinoic acid of multiple ChAT mRNAs produced from distinct promoters. Neuroreport 5:1346-1348.
12. Clementi F, Fornasari D, Gotti C. 2000. Neuronal nicotinic acetylcholine receptors: from structure to therapeutics. Trends Pharmacol Sci 21:35-37.
13. Conover JC, Ip NY, Poueymirou WT, Bates B, Goldfarb MP, DeChiara TM, Yancopoulos GD. 1993. Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells. Development 119:559-565.
14. Craig CG, Tropepe V, Morshead CM, Reynolds BA, Weiss S, van der Kooy D. 1996. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci 16:2649-2658.
15. Crosland RD. 1996. Differentiation agents enhance cholinergic characteristics of LA-N-2 human neuroblastoma cells. Life Sci 58:1987-1994.
16. Drescher DG, Khan KM, Green GE, Morley BJ, Beisel KW, Kaul H, Gordon D, Gupta AK, Drescher MJ, Barretto RL. 1995. Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 112:267-273.
17. Eriksdotter-Jonhagen M, Nordberg A, Amberla K, Backman L, Ebendal T, Meyerson B, Olson L, Seiger, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund LO. 1998. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord 9:246-257.
18. Fagan AM, Garber M, Barbacid M, Silos-Santiago I, Holtzman DM. 1997. A role for TrkA during maturation of striatal and basal forebrain cholinergic neurons in vivo. J Neurosci 177644-7654.
19. Fischer W. 1994. Nerve growth factor reverses spatial memory impairments in aged rats. Neurochem Int 25:47-52.
20. Gerzanich V, Peng X, Wang F, Wells G, Anand R, Fletcher S, Lindstrom J. 1995. Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol 48: 774-782.
21. Gotti C, Clementi F. 2004. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 74:363-396.
22. 3H)norepinephrine from a clonal line of pheochromocytoma cells (PC12) by nicotinic cholinergic stimulation. Brain Res 138:521-528.
23. Greene LA, Rukenstein A. 1981. Regulation of acetylcholinesterase activity by nerve growth factor. Role of transcription and dissociation from effects on proliferation and neurite outgrowth. J Biol Chem 256:6363-6367.
24. Greene LA, Tischler AS. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A 73:2424-2428.
25. Guan ZZ, Zhang X, Ravid R, Nordberg A. 2000. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 74:237-243.
26. Guan ZZ, Nordberg A, Mousavi M, Rinne JO, Hellstrom-Lindahl E. 2002. Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease. Brain Res 956:358-366.
27. Hefti F. 1986. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6:2155-2162.
28. Hellström-Lindahl E, Gorbounova O, Seiger A, Mousavi M, Nordberg A. 1998. Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord. Brain Res Dev Brain Res 108:147-160.
29. Henderson LP, Gdovin MJ, Liu C, Gardner PD, Maue RA. 1994. Nerve growth factor increases nicotinic ACh receptor gene expression and current density in wild-type and protein kinase A-deficient PC12 cells. J Neurosci 14:1153-1163.
30. Hill DP, Robertson KA. 1997. Characterization of the cholinergic neuronal differentiation of the human neuroblastoma cell line LA-N-5 after treatment with retinoic acid. Brain Res Dev Brain Res 102:53-67.
31. 3H] epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48:280-287.
32. Kobayashi M, Matsuoka I, Kurihara K. 1994. Cholinergic differentiation of cultured sympathetic neurons induced by retinoic acid. Induction of choline acetyltransferase-mRNA and suppression of tyrosine hydroxylase-mRNA levels. FEBS Lett 337:259-264.
33. Lauder JM, Schambra UB. 1999. Morphogenetic roles of acetylcholine. Environ Health Perspect 107(Suppl 1):65-69.
34. Le WD, Xie WJ, Kong R, Appel SH. 1997. Beta-amyloid-induced neurotoxicity of a hybrid septal cell line associated with increased tau phosphorylation and expression of beta-amyloid precursor protein. J Neurochem 69:978-985.
35. Li Y, Holtzman DM, Kromer LF, Kaplan DR, Chua-Couzens J, Clary DO, Knusel B, Mobley WC. 1995. Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J Neurosci 15:2888-2905.
36. Lipton SA, Kater SB. 1989. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci 12:265-270.
37. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
38. 3H]nicotine binding to a nicotinic cholinergic receptor on PC 12 cells. Endocrinology 130:825-830.
39. Malik MA, Greenwood CE, Blusztajn JK, Berse B. 2000. Cholinergic differentiation triggered by blocking cell proliferation and treatment with all-trans-retinoic acid. Brain Res 874:178-185.
40. Martinez HJ, Dreyfus CF, Jonakait GM, Black IB. 1985. Nerve growth factor promotes cholinergic development in brain striatal cultures. Proc Natl Acad Sci U S A 82:7777-7781.
41. Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Lena C, Le Novere N, de Kerchove d'Exaerde A, Huchet M, Damaj MI, Changeux JP. 1999. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398:805-810.
42. 3H]epibatidine. Brain Res 801:143-149.
43. Matsuoka I, Mizuno N, Kurihara K. 1989. Cholinergic differentiation of clonal rat pheochromocytoma cells (PC12) induced by retinoic acid: increase of choline acetyltransferase activity and decrease of tyrosine hydroxylase activity. Brain Res 502:53-60.
44. Mousavi M, Hellstrom-Lindahl E, Guan ZZ, Bednar I, Nordberg A. 2001. Expression of nicotinic acetylcholine receptors in human and rat adrenal medulla. Life Sci 70:577-590.
45. Mousavi M, Bednar I, Nordberg A. 2004. Selective changes in expression of different nicotinic receptor subtypes in brain and adrenal glands of mice carrying human mutated gene for APP or over-expressing human acetylcholinestrase. Int J Dev Neurosci 22:545-549.
46. Newhouse PA, Potter A, Levin ED. 1997. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11:206-228.
47. Nordberg A, Alafuzoff I, Winblad B. 1992. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J Neurosci Res 31:103-111.
48. Pakkanen JS, Jokitalo E, Tuominen RK. 2005. Up-regulation of beta2 and alpha7 subunit containing nicotinic acetylcholine receptors in mouse striatum at cellular level. Eur J Neurosci 21:2681-2691.
49. Palmer TD, Takahashi J, Gage FH. 1997. The adult rat hippocampus contains primordial neural stem cells. Mol Cell Neurosci 8:389-404.
50. Palmer TD, Schwartz PH, Taupin P, Kaspar B, Stein SA, Gage FH. 2001. Cell culture. Progenitor cells from human brain after death. Nature 411:42-43.
51. Paterson D, Nordberg A. 2000. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61:75-111.
52. Pedersen WA, Berse B, Schuler U, Wainer BH, Blusztajn JK. 1995. All-trans- and 9-cis-retinoic acid enhance the cholinergic properties of a murine septal cell line: evidence that the effects are mediated by activation of retinoic acid receptor-alpha. J Neurochem 65:50-58.
53. Pedersen WA, Kloczewiak MA, Blusztajn JK. 1996. Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc Natl Acad Sci U S A 93:8068-8071.
54. Personett D, Pass U, Panickar K, McKinney M. 2000. Retinoic acid-mediated enhancement of the cholinergic/neuronal nitric oxide synthase phenotype of the medial septal SN56 clone: establishment of a nitric oxide-sensitive proapoptotic state. J Neurochem 74:2412-2424.
55. Reynolds BA, Weiss S. 1992. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707-1710.
56. Robert I, Sutter A, Quirin-Stricker C. 2002. Synergistic activation of the human choline acetyltransferase gene by c-Myb and C/EBPbeta. Brain Res Mol Brain Res 106:124-135.
57. Rogers SW, Mandelzys A, Deneris ES, Cooper E, Heinemann S. 1992. The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF. J Neurosci 12:4611-4623.
58. Role LW, Berg DK. 1996. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16:1077-1085.
59. Scheibe RJ, Ginty DD, Wagner JA. 1991. Retinoic acid stimulates the differentiation of PC12 cells that are deficient in cAMP-dependent protein kinase. J Cell Biol 113:1173-1182.
60. Shetty AK, Turner DA. 1998. In vitro survival and differentiation of neurons derived from epidermal growth factor-responsive postnatal hippocampal stem cells: inducing effects of brain-derived neurotrophic factor. J Neurobiol 35:395-425.
61. Singh IN, Sorrentino G, McCartney DG, Massarelli R, Kanfer JN. 1990. Enzymatic activities during differentiation of the human neuroblastoma cells, LA-N-1 and LA-N-2. J Neurosci Res 25:476-485.
62. Susen K, Heumann R, Blochl A. 1999. Nerve growth actor stimulates MAPK via the low affinity receptor p75(LNTR). FEBS Lett 463:231-234.
63. Szutowicz A, Tomaszewicz M, Jankowska A, Madziar B, Bielarczyk H. 2000. Acetyl-CoA metabolism in cholinergic neurons and their susceptibility to neurotoxic inputs. Metab Brain Dis 15:29-44.
64. Takahashi T, Yamashita H, Nakamura S, Ishiguro H, Nagatsu T, Kawakami H. 1999. Effects of nerve growth factor and nicotine on the expression of nicotinic acetylcholine receptor subunits in PC12 cells. Neurosci Res 35:175-181.
65. Tuszynski MH, U Hs , Amaral DG, Gage FH. 1990. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci 10:3604-3614.
66. Tuszynski MH, Thal L, Pay M, Salmon DP, U Hs, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J. 2005. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11:551-555.
67. Whiting P, Schoepfer R, Lindstrom J, Priestley T. 1991. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol Pharmacol 40:463-472.
68. Zeller M, Strauss WL. 1995. Retinoic acid induces cholinergic differentiation of NTera 2 human embryonal carcinoma cells. Int J Dev Neurosci 13:437-445.